X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab
BackgroundX-linked hypophosphatemic rickets (XLH) is a rare genetic disease characterized by inappropriately elevated circulating fibroblast growth factor 23 (FGF-23) and subsequent urinary phosphate wasting. The primary clinical manifestations of XLH include short stature, lower extremity bowing, d...
Saved in:
Main Authors: | Neil J. Paloian (Author), Lindsey R. Boyke-Lohmann (Author), Robert D. Steiner (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum: X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteriscs of a single-center pediatric cohort in North America before and after burosumab
by: Frontiers Production Office
Published: (2024) -
Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study
by: Shelly Levi, et al.
Published: (2024) -
Endodontic treatment in patients with X-linked hypophosphatemic rickets
by: Cleverton Roberto de Andrade, et al.
Published: (2015) -
X-linked hypophosphatemic rickets: from diagnosis to management
by: Eujin Park, et al.
Published: (2024) -
X-linked hypophosphatemic rickets: an Italian experts' opinion survey
by: F. Emma, et al.
Published: (2019)